Compugen Ltd. Operating Income 2011-2026 | CGEN

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income Compugen Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
31.3 M	-14.9 M	-13 M	-35.4 M	-35.1 M	-31.5 M	-28.9 M	-23.2 M	-37.4 M	-32.6 M	-20.9 M	-12.3 M	-17 M	-13.5 M	-12 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
31.3 M	-37.4 M	-19.8 M

Operating Income of other stocks in the Biotechnology industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-508 M	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	-24 M	-	-10.17 %	$ 12.2 K	USA
Akero Therapeutics AKRO	-285 M	-	-	$ 3.67 B	USA
Midatech Pharma plc MTP	-7 M	-	-18.52 %	$ 27.3 M	Britain
AlloVir ALVR	-46.2 M	-	4.14 %	$ 49.1 M	USA
Biophytis SA BPTS	-26.8 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	31.8 M	-	2.54 %	$ 160 B	France
Aquestive Therapeutics AQST	-71.1 M	$ 4.1	1.23 %	$ 438 M	USA
ACADIA Pharmaceuticals ACAD	231 M	$ 22.45	1.13 %	$ 3.72 B	USA
Athira Pharma ATHA	-102 M	-	-	$ 269 M	USA
Applied Molecular Transport AMTI	-127 M	-	-	$ 10.1 M	USA
Ayala Pharmaceuticals AYLA	-37.5 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	1.06 B	-	-	$ 96.9 B	Britain
Berkeley Lights BLI	-98.1 M	-	-7.31 %	$ 87 M	USA
Calithera Biosciences CALA	-115 M	-	-10.95 %	$ 876 K	USA
Advaxis ADXS	-36.3 M	-	-9.65 %	$ 45.9 M	USA
CymaBay Therapeutics CBAY	-102 M	-	-	$ 3.45 B	USA
ChemoCentryx CCXI	-130 M	-	-	$ 3.74 B	USA
Cerus Corporation CERS	-8.68 M	$ 2.03	5.73 %	$ 387 M	USA
Caladrius Biosciences CLBS	-22.4 M	-	-16.75 %	$ 25.8 M	USA
Checkmate Pharmaceuticals CMPI	-61.5 M	-	-	$ 231 M	USA
Aeterna Zentaris AEZS	-8.67 M	-	5.93 %	$ 314 M	Canada
BioNTech SE BNTX	15.3 B	$ 103.45	1.85 %	$ 27.2 B	Germany
Brainstorm Cell Therapeutics BCLI	-9.95 M	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	-210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-17.7 M	-	-	$ 26.5 M	USA
Deciphera Pharmaceuticals DCPH	-211 M	-	-	$ 2.18 B	USA
AIkido Pharma AIKI	-55.7 M	-	1.93 %	$ 17.4 M	USA
Innate Pharma S.A. IPHA	-47.8 M	$ 1.44	-3.36 %	$ 235 M	France
Dynavax Technologies Corporation DVAX	-4.12 M	-	-	$ 2.02 B	USA
Akouos AKUS	-86.8 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	-196 M	-	-	$ 28.6 M	USA
Editas Medicine EDIT	-160 M	$ 3.0	6.38 %	$ 266 M	USA
Edesa Biotech EDSA	-7.01 M	$ 18.27	14.94 %	$ 58.4 M	USA
Can-Fite BioPharma Ltd. CANF	-9.95 M	$ 3.19	6.69 %	$ 5.25 M	Israel
Eiger BioPharmaceuticals EIGR	-71.8 M	-	-9.21 %	$ 2.55 M	USA
Eloxx Pharmaceuticals ELOX	-34.4 M	-	-5.68 %	$ 8.28 M	USA
CureVac N.V. CVAC	-412 M	-	-	$ 867 M	Germany
Ampio Pharmaceuticals AMPE	-33.3 M	-	-11.43 %	$ 502 K	USA
Applied Therapeutics APLT	-64.5 M	-	-	$ 8.42 M	USA
Aptinyx APTX	-62.6 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	-70.8 M	-	-13.39 %	$ 1.45 M	USA